DUK
54
4
AZO
48
5
AAL
54
3
VIX
33
4
AVGO
31
-7
ABBV
59
9
AIG
78
3
AVB
32
5
COP
42
-5
CMA
70
-3
AAPL
53
-5
BRK.B
49
6
AEE
58
8
EL
53
-3
EIX
56
2
CLX
50
-3
CINF
66
3
CA
18
-3
CNP
57
5
EA
47
-12
DUK
54
4
AZO
48
5
AAL
54
3
VIX
33
4
AVGO
31
-7
ABBV
59
9
AIG
78
3
AVB
32
5
COP
42
-5
CMA
70
-3
AAPL
53
-5
BRK.B
49
6
AEE
58
8
EL
53
-3
EIX
56
2
CLX
50
-3
CINF
66
3
CA
18
-3
CNP
57
5
EA
47
-12
Financhill
Back

Protara Therapeutics, Inc. 10K Form

Sell
49

TARA
Protara Therapeutics, Inc.

Last Price:
$5.48
Seasonality Move:
27.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TARA News And Ratings

See the #1 stock for the next 7 days that we like better than TARA

TARA Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-12.5M
Price / Cash Flow: 0
Annual Sales: $3.43
Price / Book: 1.66

Profitability

EPS (TTM): -1.44330
Net Income (TTM): $-52.9M
Gross Margin: $-332K
Return on Equity: -38.66%
Return on Assets: -35.47%

Protara Therapeutics, Inc. Earnings Forecast

Key Protara Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 7 years have been positive in 4 years.

Protara Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TARA
CUSIP: 74365U
Website: protaratx.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 13.69
Quick Ratio: 13.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TARA Technical Analysis vs Fundamental Analysis

Sell
49
Protara Therapeutics, Inc. (TARA) is a Sell

Is Protara Therapeutics, Inc. a Buy or a Sell?